Gudpres-AM 25 Tablet PR
Product Info
Prescription required | Yes |
Marketer | Mankind Pharma Ltd |
Active Ingredient | Amlodipine (5mg) + Metoprolol Succinate (25mg) |
Storage | Store below 30°C |
Habit Forming | No |
Therapeutic Class | CARDIAC |
User Rating | 4.4 |
User Reviews | 507 |
FAQ
Gudpres-AM 25 Tablet PR Reviews
You can take Gudpres-AM 25 at any time of day, with or without food, but it is best to take it at the same time each day. Keep taking it for as long as advised by your doctor. Even if you feel well, do not stop this medicine on your own because high blood pressure often has no symptoms. If you stop taking it, your condition may get worse. Keeping active with regular exercise, reducing your weight and eating a healthy diet will also help control your blood pressure. Follow your doctor’s advice while taking this medicine.
It may cause side effects like headache, ankle swelling, skin rash, slow heart rate, nausea,a nd depression. It may also cause dizziness, so do not drive or do anything that requires mental focus until you know how this medicine affects you. This might raise the level of potassium in the blood, hence avoid potassium rich food or supplements. You may be asked for regular monitoring of blood pressure, kidney function, and electrolytes level while on the treatment.
Before taking it, let your doctor know if you have any liver or kidney problems. Pregnant or breastfeeding women should also consult their doctor for advice before taking this medicine. You also need to tell your doctor what other medicines you are taking especially those used to treat high blood pressure or heart conditions.
How Gudpres-AM 25 Tablet PR Works
How to Use Gudpres-AM 25 Tablet PR
Benefits of Gudpres-AM 25 Tablet PR
- In Treatment of Hypertension (high blood pressure): Gudpres-AM 25 is a combination of two medicines. Both medicines work to lower blood pressure but in different ways. Together they help relax blood vessels, reduce heart rate, and make it easier for the heart to pump blood around the body. This leads to lower blood pressure. If blood pressure is controlled, the risk of a heart attack, stroke, or kidney problems is also reduced. This medicine must be taken regularly as prescribed for it to be effective. This medicine does not show any direct benefits, but works in the long term to keep you well. Also, make appropriate lifestyle changes (such as eating healthy and staying active) to maximize the effectiveness of this medicine.
- In Treatment of Angina (heart-related chest pain): Gudpres-AM 25 prevents the formation of blood clot. This makes blood flow more easily around your body and makes sure that your heart is getting a good supply of oxygen. Altogether, it reduces the risk of a chest pain caused by angina. This medicine might help increase your ability to exercise and go about your daily life more easily. You should take it regularly and as long as it is prescribed for it to work effectively.
Uses of Gudpres-AM 25 Tablet PR
- Treatment of Angina (heart-related chest pain)
- Treatment of Hypertension (high blood pressure)
Gudpres-AM 25 Tablet PR Side Effects
- Fatigue
- Headache
- Breathlessness
- Edema (swelling)
- Visual disturbance
- Constipation
- Slow heart rate
- Sleepiness
- Dizziness
- Nausea
- Ankle swelling
- Depression
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Orthostatic hypotension (sudden lowering of blood pressure on standing)
- Vomiting
- Skin rash
- Muscle cramp
- Palpitations
- Abdominal pain
Safety Tips
Quick Tips
- It may cause dizziness. Get up slowly when rising from a sitting or lying position.
- Let your doctor know if you are pregnant or planning for pregnancy.
- Do not stop taking the medication suddenly without talking to your doctor as it can cause sudden increase in your blood pressure.
References
- ScienceDirect. Amlodipine.
- Metoprolol succinate. Södertälje, Sweden: AstraZeneca AB; 1992 [revised 2010].
- Central Drugs Standard Control Organisation. Amlodipine+Metoprolol Succinate.
- Amlodipine besylate. New York, New York: Pfizer Inc.; 1987 [revised May 2011].